FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and biotechnology, namely concerns new stable composition of antibody specifically bound with HER2 receptors in dried form, which can be recovered by solvent, and in form of concentrated solution, as well as method for preparing composition.
EFFECT: invention can be used for creation of finished dosage form of preparation, as well as for preparing solution for infusions used for treating HER2-positive tumours.
9 cl, 1 dwg, 3 tbl, 21 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE ISOTONIC LYOPHILISED PROTEIN COMPOSITION | 1996 |
|
RU2497500C2 |
| STABLE ISOTONIC LYOPHILIZED PROTEIN COMPOSITION | 1996 |
|
RU2229288C2 |
| PHARMACEUTICAL COMPOSITIONS OF HER2 ANTIBODY CONJUGATE | 2020 |
|
RU2795196C2 |
| STABLE PROTEIN PREPARATIONS CONTAINING MOLAR EXCESS OF SORBITOL | 2015 |
|
RU2689145C2 |
| COMPOSITIONS CONTAINING ANTIBODY-DRUG CONJUGATES DUOCARMICIN | 2016 |
|
RU2687237C1 |
| NEW METHOD FOR STABILIZATION OF A BIOPHARMACEUTICAL MEDICINAL PRODUCT IN MANUFACTURE THEREOF | 2017 |
|
RU2744630C2 |
| LIQUID COMPOSITIONS OF PROTEINS CONTAINING AGENTS FOR VISCOSITY REDUCTION | 2014 |
|
RU2710542C2 |
| LIQUID PROTEIN COMPOSITIONS CONTAINING VISCOSITY-REDUCING AGENTS | 2014 |
|
RU2782765C2 |
| STABLE PHARMACEUTICAL PREPARATION BASED ON THE PD-1 ANTIBODY AND ITS USE IN MEDICINE | 2016 |
|
RU2731418C2 |
| COMPOSITIONS AND METHODS, INCLUDING ALKYLGLYCOSIDES, FOR STABILISATION OF PROTEIN-CONTAINING COMPOSITIONS | 2011 |
|
RU2575830C2 |
